According to reports, the Union Cabinet decided to not discuss the National Pharmaceutical Pricing Policy (NPPP) in a recent meeting due to concerns over the NPPP’s price-fixing mechanism policy. The finance ministry raised concerns over the NPPP, and, as a result, the delay in discussion threatens to prevent the NPPP from being finalized and submitted to the Supreme Court by its given deadline of November 25. A group of ministers had originally suggested the price-fixing mechanism, though the finance ministry has found loopholes in its legislature.
Featured News
Latham Expands Antitrust Practice With Paris Partner Hire
Sep 20, 2026 by
CPI
China Opens Competition Probes Into Meituan, Alibaba Travel Units
Sep 20, 2026 by
CPI
US Judiciary Prepares New AI Guidance for Federal Courts
Sep 20, 2026 by
CPI
EU Regulators Poised to Block UPM-Sappi Paper Venture
Sep 20, 2026 by
CPI
Paramount Nears Deal With California Officials Over $111 Billion WBD Acquisition
Sep 20, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Computational Antitrust
Sep 16, 2026 by
CPI
The Next Five Years of Computational Antitrust
Sep 16, 2026 by
Thibault Schrepel
When Two AI Agents Talk: A Gap in Detection Capabilities
Sep 16, 2026 by
Alba Ribera Martinez
When Innovation Competition Has No Product Yet: Making General Innovation Competition Operational
Sep 16, 2026 by
Mariateresa Maggiolino
Computational Antitrust for Complex Adaptive Markets
Sep 16, 2026 by
Filip Lubinski